TACC2 anticorps (AA 237-303)

N° du produit ABIN1886240

L’anticorps Lapin Polyclonal anti-TACC2 a été validé pour WB et IHC. Il convient pour détecter TACC2 dans des échantillons de Humain.

Aperçu rapide pour TACC2 anticorps (AA 237-303) (ABIN1886240)

Antigène: TACC2 (Transforming, Acidic Coiled-Coil Containing Protein 2 (TACC2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TACC2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Détail du produit anti-TACC2 anticorps

Épitope: AA 237-303

Purification: Purified by antigen-affinity chromatography.

Immunogène: Synthetic peptide contain a sequence corresponding to a region within amino acids 237 and 303 of Human TACC2

Information d'application

Indications d'application: Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: Biohazard Informations: This product contains thimerosal which is hazardous.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.

Détails sur TACC2

Antigène: TACC2 (Transforming, Acidic Coiled-Coil Containing Protein 2 (TACC2))

Autre désignation: TACC2

Sujet: Transforming acidic coiled-coil proteins are a conserved family of centrosome- and microtubule-interacting proteins that are implicated in cancer.This gene encodes a protein that concentrates at centrosomes throughout the cell cycle.This gene lies within a chromosomal region associated with tumorigenesis.Expression of this gene is induced by erythropoietin and is thought to affect the progression of breast tumors.Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq]

Poids moléculaire: 119 kDa

ID gène: 10579

NCBI Accession: NM_206861, NP_996743